BTX-9341

· Biotheryx, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BTX-9341, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer [Phase 1]

See pricing